Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.

Wong KP, Wardak M, Shao W, Dahlbom M, Kepe V, Liu J, Satyamurthy N, Small GW, Barrio JR, Huang SC.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):575-88. doi: 10.1007/s00259-009-1293-8. Epub 2009 Oct 31.

2.

Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.

Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, Small GW, Barrio JR, Huang SC.

J Nucl Med. 2010 Feb;51(2):210-8. doi: 10.2967/jnumed.109.063701. Epub 2010 Jan 15.

3.

Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.

Wong KP, Kepe V, Dahlbom M, Satyamurthy N, Small GW, Barrio JR, Huang SC.

Neuroimage. 2012 Mar;60(1):241-51. doi: 10.1016/j.neuroimage.2011.12.014. Epub 2011 Dec 16.

4.

Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.

Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson J, Sörensen J, Antoni G, Nordberg A, Lubberink M.

J Nucl Med. 2016 Apr;57(4):574-81. doi: 10.2967/jnumed.115.158519. Epub 2016 Jan 21.

5.

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.

Zhou Y, Resnick SM, Ye W, Fan H, Holt DP, Klunk WE, Mathis CA, Dannals R, Wong DF.

Neuroimage. 2007 Jun;36(2):298-312. Epub 2007 Mar 16.

6.

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).

Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ.

J Nucl Med. 2010 Jun;51(6):913-20. doi: 10.2967/jnumed.109.069088. Erratum in: J Nucl Med. 2010 Aug;51(8):1327.

7.

Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer ¹¹C-AZD2184.

Ito H, Shimada H, Shinotoh H, Takano H, Sasaki T, Nogami T, Suzuki M, Nagashima T, Takahata K, Seki C, Kodaka F, Eguchi Y, Fujiwara H, Kimura Y, Hirano S, Ikoma Y, Higuchi M, Kawamura K, Fukumura T, Böö ÉL, Farde L, Suhara T.

J Nucl Med. 2014 Jun;55(6):932-8. doi: 10.2967/jnumed.113.133793. Epub 2014 Apr 14.

8.

Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects.

Wooten DW, Guehl NJ, Verwer EE, Shoup TM, Yokell DL, Zubcevik N, Vasdev N, Zafonte RD, Johnson KA, El Fakhri G, Normandin MD.

J Nucl Med. 2017 Mar;58(3):484-491. doi: 10.2967/jnumed.115.170910. Epub 2016 Sep 22.

9.

In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317.

Betthauser TJ, Lao PJ, Murali D, Barnhart TE, Furumoto S, Okamura N, Stone CK, Johnson SC, Christian BT.

J Nucl Med. 2017 Jun;58(6):996-1002. doi: 10.2967/jnumed.116.182980. Epub 2016 Nov 10.

PMID:
27856627
10.

FDDNP binding using MR derived cortical surface maps.

Protas HD, Huang SC, Kepe V, Hayashi K, Klunder A, Braskie MN, Ercoli L, Bookheimer S, Thompson PM, Small GW, Barrio JR.

Neuroimage. 2010 Jan 1;49(1):240-8. doi: 10.1016/j.neuroimage.2009.08.035. Epub 2009 Aug 22.

11.

Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.

Cselényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, Johnström P, Varnäs K, Svensson S, Farde L.

J Nucl Med. 2012 Mar;53(3):415-24. doi: 10.2967/jnumed.111.094029. Epub 2012 Feb 9.

12.

Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?

Edison P, Hinz R, Ramlackhansingh A, Thomas J, Gelosa G, Archer HA, Turkheimer FE, Brooks DJ.

Neuroimage. 2012 Apr 15;60(3):1716-23. doi: 10.1016/j.neuroimage.2012.01.099. Epub 2012 Jan 27.

13.

PET imaging of neuropathology in tauopathies: progressive supranuclear palsy.

Kepe V, Bordelon Y, Boxer A, Huang SC, Liu J, Thiede FC, Mazziotta JC, Mendez MF, Donoghue N, Small GW, Barrio JR.

J Alzheimers Dis. 2013;36(1):145-53. doi: 10.3233/JAD-130032.

14.

White matter damage of patients with Alzheimer's disease correlated with the decreased cognitive function.

Duan JH, Wang HQ, Xu J, Lin X, Chen SQ, Kang Z, Yao ZB.

Surg Radiol Anat. 2006 May;28(2):150-6. Epub 2006 Apr 14.

PMID:
16614789
15.

Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients.

Gulyás B, Spenger C, Beliczai Z, Gulya K, Kása P, Jahan M, Jia Z, Weber U, Pfeifer A, Muhs A, Willbold D, Halldin C.

Neurochem Int. 2012 Jan;60(2):153-62. doi: 10.1016/j.neuint.2011.10.010. Epub 2011 Nov 12.

PMID:
22100791
16.

Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.

Fellgiebel A, Wille P, Müller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P.

Dement Geriatr Cogn Disord. 2004;18(1):101-8. Epub 2004 Apr 14.

PMID:
15087585
17.

Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease.

Kobayashi K, Hayashi M, Nakano H, Fukutani Y, Sasaki K, Shimazaki M, Koshino Y.

Neuropathol Appl Neurobiol. 2002 Jun;28(3):238-51.

PMID:
12060348
18.

Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.

Logan J, Ding YS, Lin KS, Pareto D, Fowler J, Biegon A.

Nucl Med Biol. 2005 Jul;32(5):531-42.

PMID:
15982584
19.

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, Hamilton RL, Ikonomovic MD, DeKosky ST, Mathis CA.

J Neurosci. 2003 Mar 15;23(6):2086-92.

20.

Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.

Seki C, Ito H, Ichimiya T, Arakawa R, Ikoma Y, Shidahara M, Maeda J, Takano A, Takahashi H, Kimura Y, Suzuki K, Kanno I, Suhara T.

Ann Nucl Med. 2010 May;24(4):249-60. doi: 10.1007/s12149-010-0364-z. Epub 2010 Apr 3.

PMID:
20364374

Supplemental Content

Support Center